PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.25
Bid: 1.10
Ask: 1.40
Change: 0.00 (0.00%)
Spread: 0.30 (27.273%)
Open: 1.25
High: 1.25
Low: 1.25
Prev. Close: 1.25
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Physiomics falls as lowers full-year guidance

Tue, 23rd May 2023 10:32

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

----------

AIM - WINNERS

----------

Southern Energy Corp, up 18% at 23.55 pence, 12-month range 16.00p-91.00p. The natural gas exploration and production company enters a deal with PetroTX Energy LLC to buy the remaining producing acreage in the Gwinville Field in US state of Mississippi. Southern Energy will buy the remaining acreage at Gwinville in Jefferson Davis County for USD3.2 million in cash. Under the terms of the agreement, the firm also agrees to grant PetroTX minor overriding royalties over two of the asset's wells, which currently are not producing and would require remedial work to re-commence production. Chief Executive Officer Ian Atkinson says: "The finding, development and acquisition metrics of the assets are outstanding and will add over 20 Selma Chalk drilling locations to our already deep inventory in the Gwinville Field."

----------

AIM - LOSERS

----------

Eneraqua Technologies PLC, down 35% at 168.50p, 12-month range 165.00p-389.60p. The energy and water efficiency solutions provider says revenue in the financial year that ended January 31 jumps 52% to GBP55.1 million from GBP36.2 million the year before. This was below market expectations, which Eneraqua in March said were between GBP61.3 million and GBP61.5 million. Pretax profit surges to GBP9.9 million from GBP4.1 million. Eneraqua explained that growth was driven repeat customer orders, new client wins, geographic expansion, and the entering of new markets. The company increases its full-year dividend by 20% to 1.2p from 1.0p. Looking ahead, Eneraqua says it has a "record order book" of GBP130.4 million. About 62% of the order book is currently anticipated to be delivered in financial 2024.

----------

Physiomics PLC, down 17% at 2.24p, 12-month range 1.78p-6.60p. The oncology consultancy says it now expects total income for the financial year ending June 30 to be more than 10% lower than the GBP750,000 given in its previous guidance. It now expects total income to be about GBP660,000. It explains that this is due to unforeseen delays in data delivery to Physiomics for contracted projects and the signing of a project with a potential new client.

----------

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 Mar 2022 20:28

TRADING UPDATES: MediaZest virus hit; SpaceandPeople Network Rail deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
23 Feb 2022 14:48

IN BRIEF: Physiomics chair steps down after 15 years; CEO adds role

Physiomics PLC - oncology consultancy based in Oxford, England - Non-Executive Chair Paul Harper steps down from board immediately, having served on the board since 2004 and as chair since 2007. Chief Executive Officer Jim Millen will take on the additional role of executive chair. Physiomics also will recruit one independent non-executive director "as soon as possible".

Read more
21 Feb 2022 14:31

IN BRIEF: Physiomics shares up on continued DoseMeRx collaboration

Physiomics PLC - oncology consultancy based in Oxford - Confirms it will continue to collaborate with DoseMeRx, after Tabula Rasa Healthcare Inc announces it will sell DoseMeRx. The collaboration will explore further commercial opportunities in cancer field. Over 2021, Physiomics' personalised dosing application for docetaxel prostate cancer treatment was integrated into DoseMeRx platform, and was met with positive feedback.

Read more
22 Dec 2021 21:22

TRADING UPDATES: Mercia buys more Intechnica; Anexo scores VW win

TRADING UPDATES: Mercia buys more Intechnica; Anexo scores VW win

Read more
13 Dec 2021 20:22

IN BRIEF: Physiomics signs new deals with Merck worth GBP300,000

IN BRIEF: Physiomics signs new deals with Merck worth GBP300,000

Read more
13 Dec 2021 13:31

Physiomics signs £0.3m of new agreements with Merck

(Sharecast News) - Oncology consulting company Physiomics announced on Monday that it has signed new agreements with its existing client Merck with a total value of £0.3m.

Read more
16 Nov 2021 16:09

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
22 Oct 2021 13:06

IN BRIEF: Physiomics pens further deals with Merck KGaA

IN BRIEF: Physiomics pens further deals with Merck KGaA

Read more
22 Oct 2021 09:13

Physiomics awarded further contracts with Merck

(Sharecast News) - Oncology drug development consultancy Physiomics said on Friday that it had been awarded two further contracts by existing client Merck.

Read more
30 Sep 2021 15:45

EARNINGS UPDATES: Northbridge "delighted"; Echo Energy loss narrows

EARNINGS UPDATES: Northbridge "delighted"; Echo Energy loss narrows

Read more
23 Sep 2021 15:59

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
16 Sep 2021 20:36

IN BRIEF: Physiomics recruits first patient for Partner study

IN BRIEF: Physiomics recruits first patient for Partner study

Read more
21 May 2021 17:51

TRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy

TRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy

Read more
21 May 2021 11:48

AIM WINNERS & LOSERS: Arkle finds gold; Staffline raises cash

AIM WINNERS & LOSERS: Arkle finds gold; Staffline raises cash

Read more
21 May 2021 09:53

Physiomics inks further contracts with Bicycle Therapeutics

(Sharecast News) - Oncology drug development consultancy Physiomics said on Friday that it has been awarded two further contracts by existing client Bicycle Therapeutics.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.